These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 2546480

  • 61. EMIT cannabinoid assay: confirmation by RIA and GC/MS.
    O'Connor JE, Rejent TA.
    J Anal Toxicol; 1981; 5(4):168-73. PubMed ID: 7024638
    [Abstract] [Full Text] [Related]

  • 62. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay.
    Dasgupta A, Saldana S, Kinnaman G, Smith M, Johansen K.
    Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030
    [Abstract] [Full Text] [Related]

  • 63. Urinary screening for alprazolam and its major metabolites by the Abbott ADx and TDx analyzers with confirmation by GC/MS.
    Fraser AD, Bryan W, Isner AF.
    J Anal Toxicol; 1991 Jan; 15(1):25-9. PubMed ID: 2046338
    [Abstract] [Full Text] [Related]

  • 64. Extending the detection limit of the TDx fluorescence polarization immunoassay for benzoylecgonine in urine.
    de Kanel J, Dunlap L, Hall TD.
    Clin Chem; 1989 Oct; 35(10):2110-2. PubMed ID: 2791279
    [Abstract] [Full Text] [Related]

  • 65. Metabolic study of pholcodine in urine using enzyme multiplied immunoassay technique (EMIT) and capillary gas chromatography.
    Johansen M, Rasmussen KE, Christophersen AS, Skuterud B.
    Acta Pharm Nord; 1991 Oct; 3(2):91-4. PubMed ID: 1910552
    [Abstract] [Full Text] [Related]

  • 66. Detectability of phencyclidine and 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in adulterated urine by radioimmunoassay and fluorescence polarization immunoassay.
    Bronner W, Nyman P, von Minden D.
    J Anal Toxicol; 1990 Oct; 14(6):368-71. PubMed ID: 1964989
    [Abstract] [Full Text] [Related]

  • 67. One hundred EMIT positive cannabinoid urine samples confirmed by BPA/TLC, RIA, and GC/MS.
    Verebey K, Mulé SJ, Alrazi J, Lehrer M.
    J Anal Toxicol; 1986 Oct; 10(2):79-80. PubMed ID: 3517489
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. A rapid sample-preparation technique for thin-layer chromatographic analysis for 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in human urine.
    King DL, Gabor MJ, Martel PA, O'Donnell CM.
    Clin Chem; 1989 Jan; 35(1):163-6. PubMed ID: 2535972
    [Abstract] [Full Text] [Related]

  • 70. Adsorption losses from urine-based cannabinoid calibrators during routine use.
    Blanc JA, Manneh VA, Ernst R, Berger DE, de Keczer SA, Chase C, Centofanti JM, DeLizza AJ.
    Clin Chem; 1993 Aug; 39(8):1705-12. PubMed ID: 8394791
    [Abstract] [Full Text] [Related]

  • 71. Comparison of lidocaine by fluorescence polarization immunoassay, enzyme immunoassay, and high resolution gas chromatography.
    Bertol E, Mari F, Torracca F.
    J Anal Toxicol; 1987 Aug; 11(3):122-4. PubMed ID: 3298856
    [Abstract] [Full Text] [Related]

  • 72. Direct stopped-flow fluorescence polarization immunoassay of abused drugs and their metabolites in urine.
    Pérez-Bendito D, Gómez-Hens A, Gaikwad A.
    Clin Chem; 1994 Aug; 40(8):1489-93. PubMed ID: 8044987
    [Abstract] [Full Text] [Related]

  • 73. [Discrepant results with immunohistochemical detection TDx/ADx?].
    Franke M, Goenechea S, Heinbach F.
    Beitr Gerichtl Med; 1992 Aug; 50():105-9. PubMed ID: 1489309
    [Abstract] [Full Text] [Related]

  • 74. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine.
    D'Nicuola J, Jones R, Levine B, Smith ML.
    J Anal Toxicol; 1992 Aug; 16(4):211-3. PubMed ID: 1501473
    [Abstract] [Full Text] [Related]

  • 75. A semi-automated extraction and spotting system for drug analysis by TLC. I. Procedure for analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine.
    Vinson JA, Lopatofsky DJ.
    J Anal Toxicol; 1985 Aug; 9(1):6-9. PubMed ID: 2984464
    [Abstract] [Full Text] [Related]

  • 76. A comparison of five commercial immunoassays for the detection of flunitrazepam and other benzodiazepines in urine.
    Barrett AM, Walshe K, Kavanagh PV, McNamara SM, Moran C, Burdett J, Shattock AG.
    Addict Biol; 1999 Jan; 4(1):81-7. PubMed ID: 20575774
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Gas chromatographic-mass spectrometric confirmation of radioimmunoassay results for cannabinoids in blood and urine.
    Clatworthy AJ, Oon MC, Smith RN, Whitehouse MJ.
    Forensic Sci Int; 1990 Jul; 46(3):219-30. PubMed ID: 2376363
    [Abstract] [Full Text] [Related]

  • 79. An evaluation of six methods for the detection of drugs of abuse in urine.
    Simpson D, Jarvie DR, Heyworth R.
    Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():172-81. PubMed ID: 2729861
    [Abstract] [Full Text] [Related]

  • 80. Specificity of the cannabinoid metabolite and phencyclidine EMIT d.a.u. assays.
    Allen LV, Stiles ML.
    J Anal Toxicol; 1988 Mar; 12(1):45-7. PubMed ID: 3280873
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.